Showcases Stock ranks

Bristol-Myers Squibb Company (BMY) (BMY)
52.79 0.54 (1.03%) 03-27 16:02
Open: 51.11 Pre. Close: 52.25
High: 53.78 Low: 50.87
Volume: 14,498,371 Market Cap: 119435M
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 53.785 - 53.973 53.973 - 54.144
Low: 50.356 - 50.59 50.59 - 50.805
Close: 52.43 - 52.764 52.764 - 53.07
Stock Technical Analysis
Target: Six months: 67.38
One year: 75.99
Support: Support1: 45.76
Support2: 38.07
Resistance: Resistance1: 57.69
Resistance2: 65.06
Pivot: 52.17
Moving Averages: MA(5): 50.01
MA(20): 54.22
MA(100): 60.75
MA(250): 52.96
MACD: MACD(12,26): -3.20
Signal(12,26,9): -3.34
%K %D: %K(14,3): 40.05
%D(3): 28.72
RSI: RSI(14): 44.20
52-Week: High: 68.34
Low: 42.48
Change(%): 12.1
Average Vol(K): 3-Month: 1608673
10-Days: 1974592
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

BMY has closed below upper band by 45.3%. Bollinger Bands are 94.8% wider than normal. The large width of the bands suggest high volatility as compared to BMY's normal range. The bands have been in this wide range for 21 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate. Here are the key catalysts that may impact biotech stocks in the unfolding week. Conferences Most conferences stand cancelled in the wake of the COVID-19 pandemic, but a few have opted to go ahead with virtual conferences. The American College of Cardiology or ACC's, 69th Annual Scientific Session together with the World Congress of Cardiology, or WCC, Virtual Conference - ACC.20/WCC Virtual: March 28-30 See Also: Abbott Labs To Launch Point-Of-Care Test That Can Detect Coronavirus Within 5 Minutes PDUFA Dates The FDA is set to rule on AstraZeneca plc's (NYSE: AZN ) sBLA for Imfinzi in previously untreated patients with extensive-stage small cell lung cancer. The PDUFA action date has been fixed for the first quarter. Acceleron Pharma Inc (NASDAQ: XLRN ) and Bristol-Myers Squibb Co (NYSE: BMY ) await FDA decision on their sBLA for luspatercept in myelodysplastic syndromes. (Saturday) Clinical Readouts Myokardia Inc (NASDAQ: MYOK ) will present during a late-breaker session at ACC.20/WCC Virtual, data from the Phase 2 dose-ranging study of …

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with Active Disease
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--BMS Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA for the Treatment….

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 2340.00
Shares Float (M) 2250.00
% Held by Insiders 0.10
% Held by Institutions 79.85
Shares Short (K) 48970
Shares Short Prior Month (K) 63720
Stock Financials
EPS 2.010
Book Value (p.s.) 22.920
PEG Ratio 0.66
Profit Margin 13.15
Operating Margin 27.02
Return on Assets (ttm) 5.3
Return on Equity (ttm) 10.5
Qtrly Rev. Growth 33.0
Gross Profit (p.s.) 8.090
Sales Per Share 11.171
EBITDA (p.s.) 3.735
Qtrly Earnings Growth
Operating Cash Flow (M) 8070.00
Levered Free Cash Flow (M) 6160.00
Stock Valuation
P/E 26.27
P/E Growth Ratio 0.01
P/BV 2.30
P/CF 15.31
Dividend Yield 0.03
Dividends & Splits
Dividend 1.680
Dividend Pay Date 2020-04-30
Ex-Dividend Date 2020-04-01
Forward Dividend 1.800
Last Split Date
Last Split Ratio -2.1

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator